GSK.L (GSK.L) News
Track canonical SquawkNews coverage tagged to GSK.L, GSK.L. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
FTSE 100 closes 0.20% lower at 10,751 points
The FTSE 100 index fell 21 points (0.20%) on Friday to close at 10,751 points, with Antofagasta, GlaxoSmithKline and Burberry leading losses while The Sage Group, Experian and Pershing Square Holdings Ord gained.
EQUITY | Aug 14, 2026, 04:12 PM UTC
L
GSK GSK - guiding to more than 31% margin in 2026 - conf call
GSK GSK - guiding to more than 31% margin in 2026 - conf call
EQUITY | Jul 28, 2026, 01:54 PM UTC
L
GSK CEO- we think have got a large enough revenue and Income stream to offset hiv patent loss- Media call
GSK CEO- we think have got a large enough revenue and Income stream to offset hiv patent loss- Media call
EQUITY | Jul 28, 2026, 12:04 PM UTC
L
GSK reports Q2 core EPS 50.5p, up 9% at CER
Reports Q2 revenue GBP...
EARNINGS | Jul 28, 2026, 11:31 AM UTC
L
GSK Q2 SALES GBP 8,409 MILLION VS. IBES ESTIMATE GBP 8,239 MILLION || Q2 ADJUSTED OPERATING PROFIT GBP 2,800 MILLION VS. IBES ESTIMATE GBP 2
GSK Q2 SALES GBP 8,409 MILLION VS. IBES ESTIMATE GBP 8,239 MILLION || Q2 ADJUSTED OPERATING PROFIT GBP 2,800 MILLION VS. IBES ESTIMATE GBP 2,646 MILLION || Q2 ADJUSTED EPS GBP 0.505 VS. IBES ESTIMATE GBP 0.46 || OUTLOOK
EQUITY | Jul 28, 2026, 11:02 AM UTC
L
GSK ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in trea
GSK ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV
EQUITY | Jul 27, 2026, 05:00 PM UTC
H
UK's FTSE 100 Flat as US-Iran Tension Resurfaces
() -- London's FTSE 100 ended little changed at 0.02% in the red on Monday, as investors evaluated the exchange of hostilities between the US and Iran over the weekend, with Iran claiming the effective closure of the Str
CENTRAL_BANK | Jul 13, 2026, 03:55 PM UTC